Nicole Fawcett is the manager of cancer communication for the University of Michigan Comprehensive Cancer Center, overseeing media relations, marketing, web, internal communication, social media and publications for the center’s research and clinical enterprises. She leads a team of four communicators who produce targeted, innovative communication to meet the Cancer Center’s goals. Nicole joined the University of Michigan Health System in 2003. Prior to that, she was at the Detroit News and at a startup web-based community for people with disabilities.
A new study identifies a biomarker that rises just before patients’ cancer comes back — which could provide a window for earlier treatment.
Researchers did not see these differences when radiation was added to autologous reconstruction.
Changes in epigenetics suggest a predictive marker for childhood ependymomas and similarities with DIPG tumors.
Roughly 1 in 50 promising cancer drug candidates makes it to market. What’s holding the other 49 back?
The finding suggests a potential therapy to slow the disease in patients or a possible preventive strategy for women at high risk for ovarian cancer.